Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT00020332 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: alvocidib
DRUG: docetaxel

Sponsor

National Cancer Institute (NCI)